Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Vera Therapeutics, Inc. Class A Common Stock](/topic/$vera)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$vera/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$vera/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +10%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2025-02-07  
**1-Year Low**: XX% on 2025-04-19  

**Most Supportive Themes**
- **Positive Clinical Trial Results:** (40%) Vera Therapeutics' atacicept drug showed positive results in a kidney disease trial.
- **M&A Potential:** (30%) Goldman Sachs identifies Vera Therapeutics as a potential M&A candidate.
  
**Most Critical Themes**
- **Government Shutdown Impact:** (30%)  The US government shutdown is impacting FDA drug approval applications, potentially delaying Vera Therapeutics.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %   |
| ------- | -------- | -  | ------- | -   | -------- | -   |
| X       | X        | X% | XX      | XX% | XXX      | XX% |
| Reddit  | X        | X% | X       | X%  | X        | X%  |
|         |          |    |         |     |          |     |
| Total   | X        | X% | XX      | XX% | XXX      | XX% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Vera Therapeutics, Inc. Class A Common Stock

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +10%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2025-02-07
1-Year Low: XX% on 2025-04-19

Most Supportive Themes

  • Positive Clinical Trial Results: (40%) Vera Therapeutics' atacicept drug showed positive results in a kidney disease trial.
  • M&A Potential: (30%) Goldman Sachs identifies Vera Therapeutics as a potential M&A candidate.

Most Critical Themes

  • Government Shutdown Impact: (30%) The US government shutdown is impacting FDA drug approval applications, potentially delaying Vera Therapeutics.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X X X% XX XX% XXX XX%
Reddit X X% X X% X X%
Total X X% XX XX% XXX XX%
Vera Therapeutics, Inc. Class A Common Stock (VERA) Sentiment
/topic/$vera/sentiment